English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51217344    Online Users :  800
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"po lan"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 11-40 of 40  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2023 Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score study Kuo;Chin-Wei;Lin;Chien-Yu;Wei;Sheng-Huan;Chou;Yun-Tse;Chen;Chian-Wei;Tsai;Jeng-Shiuan;Su;Po-Lan;Lin;Chien-Chung
國立成功大學 2022-12 Spontaneous Breathing and Pendelluft in Patients with Acute Lung Injury: A Narrative Review Su;Po-Lan;Zhao;Zhanqi;Ko;Yen-Fen;Chen;Chang-Wen;Cheng;Kuo-Sheng
國立成功大學 2022-12 Oropharyngeal Rehabilitation for Patients With Moderate to Severe Obstructive Sleep Apnea After Transoral Robotic Surgery Lai;Yi-Ju;Su;Po-Lan;Li;Chung-Yi;Lin;Chung-Ying;Hung;Ching-Hsia;Lin;Cheng-Yu
國立成功大學 2022-11 Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio Tsai;Jeng-Shiuan;Wei;Sheng-Huan;Chen;Chian-Wei;Yang;Szu-Chun;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2022-08-11 Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin Lin;Chien-Yu;Wei;Sheng-Huan;Chen;Yi-Lin;Lee;Chung-Ta;Wu;Shang-Yin;Ho;Chung-Liang;Pavlick;Dean, C.;Su;Po-Lan;Lin;Chien-Chung
國立成功大學 2022-06 Respiratory etiological surveillance among quarantined patients with suspected lower respiratory tract infection at a medical center in southern Taiwan during COVID-19 pandemic Huang;Chien-Ping;Tsai;Chin-Shiang;Su;Po-Lan;Huang;Tang-Hsiu;Ko;Wen-Chien;Lee;Nan-Yao
國立成功大學 2022-04 Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients-A retrospective cohort study Kuo;Chin-Wei;Wang;Sheng-Yuan;Tsai;Huey-Pin;Su;Po-Lan;Cia;Cong-Tat;Lai;Ching-Han;Chen;Chang-Wen;Shieh;Chi-Chang;Lin;Sheng-Hsiang
國立成功大學 2022-03-18 Durable Response of Dabrafenib, Trametinib, and Capmatinib in an NSCLC Patient With Co-Existing BRAF-KIAA1549 Fusion and MET Amplification: A Case Report Chou;Yun-Tse;Lin;Chien-Chung;Lee;Chung-Ta;Pavlick;Dean, C.;Su;Po-Lan
國立成功大學 2022-02-28 The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2022-02 Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report Lin;Chung-Fu;Liu;Szu-Yu;Lo;Tzu-Kun;Lee;Julia, Yu-Yun;Su;Po-Lan
國立成功大學 2022-01 The occurrence of and risk factors for developing acute critical illness during quarantine as a response to the COVID-19 pandemic Tsai;Chin-Shiang;Huang;Tang-Hsiu;Su;Po-Lan;Chen;Chiung-Zuei;Chen;Chang-Wen;Ko;Wen-Chien;Lee;Nan-Yao
國立成功大學 2022-01 Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors Wang;Sheng-Yuan;Lai;Ching-Han;Chen;Chian-Wei;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2022-01 Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019 Wu;Chi-Jung;Cia;Cong-Tat;Wang;Hsuan-Chen;Chen;Chang-Wen;Lin;Wei-Chieh;Lee;Jen-Chieh;Chen;Po-Sheng;Hsieh;Chih-Cheng;Li;Wei-Ting;Su;Po-Lan;Liao;Xin-Min;Hsieh;Ming-;I;Choi;Pui-Ching;Ko;Wen-Chien
國立成功大學 2021-12 Electrical Impedance Tomography Analysis Between Two Similar Respiratory System Compliance During Decremetal PEEP Titration in ARDS Patients Su;Po-Lan;Lin;Wei-Chieh;Ko;Yen-Fen;Cheng;Kuo-Sung;Chen;Chang-Wen
國立成功大學 2021-11 Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report Wu;Chi-Hao;Su;Po-Lan;Hsu;Che-Wei;Chu;Chang-Yao;Lin;Chien-Chung
國立成功大學 2021-09 EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2021-03-29 Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy Chang;Hsien-Yuan;Lee;Chun-Hui;Su;Po-Lan;Li;Sin-Syue;Chen;Ming-Yueh;Chen;Ya-Ping;Hsu;Ya-Ting;Tsai;Wei-Chuan;Liu;Ping-Yen;Chen;Tsai-Yun;Liu;Yen-Wen
國立成功大學 2021-03 Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC Lin;Chien-Chung;Wu;Chin-You;Tseng;Joseph, Ta-Chien;Hung;Chun-Hua;Wu;Shang-Yin;Huang;Yu-Ting;Chang;Wei-Yuan;Su;Po-Lan;Su;Wu-Chou
國立成功大學 2021-02 First-line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation-positive non-small cell lung cancer Su;Po-Lan;Chen;Chian-Wei;Wu;Yi-Lin;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2020-12 Effects of a comprehensive physical therapy on moderate and severe obstructive sleep apnea- a preliminary randomized controlled trial Lin;Hsin-Yu;Chang;Chih-Ju;Chiang;Chan-Chi;Su;Po-Lan;Lin;Cheng-Yu;Hung;Ching-Hsia
國立成功大學 2020-12 Models of anatomically based oropharyngeal rehabilitation with a multilevel approach for patients with obstructive sleep apnea: a meta-synthesis and meta-analysis Lin;Hsin-Yu;Su;Po-Lan;Lin;Cheng-Yu;Hung;Ching-Hsia
國立成功大學 2020-04-15 Alpha-1 adrenergic antagonists use increases the risk of sleep apnea: implications for understanding the role of prazosin in posttraumatic stress syndrome response Su;Po-Lan;Lin;Cheng-Yu;Lin;Sheng-Hsiang
國立成功大學 2020-01 Human herpesvirus 8-related primary effusion lymphoma in four HIV-uninfected patients without organ transplantation Kuo;Hung-;I;Yu;Yu-Ting;Chang;Kung-Chao;Su;Po-Lan;Li;Sin-Syue;Huang;Tang-Hsiu
國立成功大學 2019-11-15 Alpha-1 Adrenergic-Antagonist Use Increases the Risk of Sleep Apnea: A Nationwide Population-Based Cohort Study Su;Po-Lan;Lin;Wen-Kuei;Lin;Cheng-Yu;Lin;Sheng-Hsiang
國立成功大學 2019-10 Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment Su;Po-Lan;Yang;Szu-Chun;Chen;Yi-Lin;Wu;Yi-Lin;Lin;Chia-Ying;Chang;Wei-Yuan;Tseng;Yau-Lin;Lai;Wu-Wei;Ho;Chung-Liang;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2019-08 Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC Lin;Chia-Ying;Chang;Chao-Chun;Su;Po-Lan;Lin;Chien-Chung;Tseng;Yau-Lin;Su;Wu-Chou;Yen;Yi-Ting
國立成功大學 2018-09-25 Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer Su;Po-Lan;Wu;Yi-Lin;Chang;Wei-Yuan;Ho;Chung-Liang;Tseng;Yau-Lin;Lai;Wu-Wei;Su;Wu-Chou;Lin;Chien-Chung;Yang;Szu-Chun
國立成功大學 2018-03-1 Comparison of different staging methods for COPD in predicting outcomes Huang;Tang-Hsiu;Hsiue;Tzuen-Ren;Lin;Sheng-Hsiang;Liao;Xin-Ming;Su;Po-Lan;Chen;Chiung-Zuei
國立成功大學 2018-03 Positive end-expiratory pressure selection based on best respiratory system compliance or collapse/hyperdistension curves in patients with acute respiratory distress syndrome: lack of correlation with alveolar recruitment Su;Po-Lan;Lin;Wei-Chieh;Ko;Yen-Fen;Su;Pei-Fang;Chen;Chang-Wen
國立成功大學 2018-02-15 The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis Chang;Wei-Yuan;Wu;Yi-Lin;Su;Po-Lan;Yang;Szu-Chun;Lin;Chien-Chung;Su;Wu-Chou

Showing items 11-40 of 40  (1 Page(s) Totally)
1 
View [10|25|50] records per page